Research confirms oral BPC-157 prevents gastric lesions from alcohol (Becejac et al., 2018)
Weight-loss and energy outcomes depend on diet, exercise, adherence, baseline nutritional status, and individual response to treatment
However, REGEN does not prevent future injuries, so users returning to activities that caused the original injury risk re-injury if underlying biomechanics or training errors are not addressed
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Long-Term Risks: What We Don't Know This is arguably the most vital part of this guide
Olszewski and McCully, 1993)
PMC 7752134